We are live on ! Find out more
HCM

Hoplite Capital Management Portfolio holdings

AUM $15.1M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+12.88%
1 Year Est. Return
-27.41%
3 Year Est. Return
+32.9%
5 Year Est. Return
+85.27%
10 Year Est. Return
–
AUM
$3.56B
AUM Growth
+$742M
Cap. Flow
+$451M
Cap. Flow %
12.68%
Top 10 Hldgs %
44.63%
Holding
43
New
12
Increased
9
Reduced
11
Closed
4

Top Buys

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$112M
2
AGN
Allergan plc
AGN
+$91.2M
3
ADBE icon
Adobe
ADBE
+$89.6M
4
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
+$80.9M
5
HLF icon
Herbalife
HLF
+$69.7M

Top Sells

Rank Stock Value
1
CX icon
Cemex
CX
+$138M
2
TWX
Time Warner Inc
TWX
+$103M
3
CRI icon
Carter's
CRI
+$64.9M
4
UHS icon
Universal Health Services
UHS
+$61.6M
5
EL icon
Estee Lauder
EL
+$50.9M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 26.29%
2 Healthcare 23.23%
3 Consumer Staples 18.25%
4 Technology 8.9%
5 Communication Services 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGN
1
DELISTED
Allergan plc
AGN
$245M 6.88%
1,456,859
+583,683
+67% +$91.2M
HRB icon
2
H&R Block
HRB
$5.18B
$197M 5.53%
6,770,650
-1,567,002
-19% -$44.5M
LOW icon
3
Lowe's Companies
LOW
$116B
$180M 5.05%
3,624,576
+1,333,571
+58% +$64.8M
BHC icon
4
Bausch Health
BHC
$1.65B
$163M 4.59%
1,388,953
+250,733
+22% +$27.5M
MNST icon
5
Monster Beverage
MNST
$91.4B
$159M 4.47%
14,068,782
+6,483,066
+85% +$63.7M
JAZZ icon
6
Jazz Pharmaceuticals
JAZZ
$15.9B
$137M 3.86%
+1,084,304
New +$112M
MHK icon
7
Mohawk Industries
MHK
$6.9B
$136M 3.81%
910,988
-246,952
-21% -$33.7M
OPLN
8
Openlane
OPLN
$4.17B
$135M 3.79%
12,055,615
+4,038,955
+50% +$43.8M
DG icon
9
Dollar General
DG
$25.9B
$119M 3.35%
1,976,899
-734,756
-27% -$43.2M
EQIX icon
10
Equinix
EQIX
$107B
$117M 3.29%
659,718
-259,016
-28% -$43.1M
TMO icon
11
Thermo Fisher Scientific
TMO
$211B
$106M 2.98%
952,437
– –
EL icon
12
Estee Lauder
EL
$29B
$103M 2.91%
1,373,545
-702,899
-34% -$50.9M
NBIS
13
Nebius Group N.V.
NBIS
$47.7B
$102M 2.88%
2,369,277
-576,724
-20% -$22.4M
BUD icon
14
AB InBev
BUD
$158B
$101M 2.85%
951,308
+444,721
+88% +$45.4M
VOD icon
15
Vodafone
VOD
$34.9B
$100M 2.82%
2,501,550
+308,028
+14% +$11.6M
ADBE icon
16
Adobe
ADBE
$89.5B
$97.1M 2.73%
+1,621,130
New +$89.6M
PBI icon
17
Pitney Bowes
PBI
$2.42B
$93.4M 2.63%
4,007,384
-8,729
-0.2% -$188K
DLTR icon
18
Dollar Tree
DLTR
$23.1B
$87.1M 2.45%
1,543,397
-523,523
-25% -$30.2M
PRKS icon
19
United Parks & Resorts
PRKS
$2.11B
$80.8M 2.27%
2,808,159
+36,343
+1% +$1.08M
ZNGA
20
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$79.4M 2.23%
+20,906,203
New +$80.9M
HLF icon
21
Herbalife
HLF
$1.23B
$79.1M 2.23%
+2,010,600
New +$69.7M
ADSK icon
22
Autodesk
ADSK
$44.3B
$78.7M 2.21%
+1,563,233
New +$68.5M
EXP icon
23
Eagle Materials
EXP
$6.6B
$78.4M 2.21%
1,012,864
+615,459
+155% +$46.3M
CRI icon
24
Carter's
CRI
$1.43B
$77.1M 2.17%
1,073,919
-911,076
-46% -$64.9M
AWI icon
25
Armstrong World Industries
AWI
$6.86B
$68.8M 1.94%
+1,194,851
New +$64.1M
1
2

Similar funds

PCP
Prisma Capital Partners New York $17.5M AUM 42.28% 1-Year Est. Return
DCM
Dynamic Capital Management St. Helier, Jersey $12M AUM 0.65% 1-Year Est. Return
FCM
Force Capital Management New York $11.4M AUM 5.65% 1-Year Est. Return
RGNCM
R.G. Niederhoffer Capital Management New York $11.3M AUM
ICP
IBIS Capital Partners London, United Kingdom $19.4M AUM 0.49% 1-Year Est. Return
PVAM
Pacific View Asset Management San Francisco, California $20.8M AUM 20.08% 1-Year Est. Return
CIM
Consilium Investment Management Ft. Lauderdale, Florida $21M AUM 29.5% 1-Year Est. Return
LAM
Lyxor Asset Management New York $8.58M AUM 3.07% 1-Year Est. Return

Hoplite Capital Management's Q4 2013 Portfolio in Review

As of Q4 2013, Hoplite Capital Management held 43 positions worth $3.56B, up 26% from $2.81B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Hoplite Capital Management deployed $451M of net new capital in Q4 2013, opening 12 new positions and adding to 9 existing holdings. Its largest new stake was Jazz Pharmaceuticals: 1,084,304 shares worth $137M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 26% of assets, down from 32% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Carter's, an estimated $64.9M trimmed.

  • Hoplite Capital Management's largest Q4 2013 buy was Jazz Pharmaceuticals: 1,084,304 shares worth $137M.
  • Hoplite Capital Management added most to Allergan plc in Q4 2013, an estimated $91.2M increase.
  • Hoplite Capital Management's biggest Q4 2013 reduction was Carter's, cutting an estimated $64.9M.
  • Hoplite Capital Management fully exited Cemex in Q4 2013, selling an estimated $138M.
  • Hoplite Capital Management's ten largest holdings make up 45% of its $3.56B portfolio in Q4 2013.
  • Hoplite Capital Management opened 12 new positions and closed 4 in Q4 2013.
  • Hoplite Capital Management's portfolio value rose 26% quarter-over-quarter to $3.56B.

Based on Hoplite Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.